Improving Patient Outcomes & Saving Lives

At ZOLL, we’re passionate about improving patient outcomes and helping save lives.

We provide innovative technologies that make a meaningful difference in people’s lives. Our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions.

Founded in 1980, ZOLL is named after Dr. Paul Zoll, whose pioneering work in cardiology and resuscitation earned him the nickname “The Father of Modern Electrophysiology.”

Today, ZOLL is a global leader in acute critical care and related software and diagnostic tools.

How We Help

Every day, people face serious health conditions and life-threatening emergencies. ZOLL solutions aid in the diagnosis, treatment, real-time response, and operational processes needed to make better outcomes possible. We provide a comprehensive portfolio of medical devices and software solutions that:

Improve outcomes for patients with serious cardiopulmonary and respiratory conditions
Help advance emergency care and save lives
Increase clinical and operational efficiencies

Late-breaking Analysis From the remedē® System Pivotal Trial

LATE-BREAKING ANALYSIS FROM THE REMEDĒ^® SYSTEM PIVOTAL TRIAL SUGGESTS FAVORABLE OUTCOMES FOR HEART FAILURE (HF) PATIENTS WITH CENTRAL SLEEP APNEA RECEIVING PHRENIC NERVE STIMULATION

ZOLL Receives Innovative Technology Contract from Vizient for TherOx SuperSaturated Oxygen (SSO₂) Therapy

April 2, 2024 — CHELMSFORD, MASS. — ZOLL^®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of hospital experts who serve on one of Vizient’s customer-led councils, and it signifies unique qualities that potentially bring improvement to patient cardiovascular care.

ZOLL Receives FDA Clearance and CE Mark to Expand the Thermogard Platform – All-In-One Core and Surface Cooling

January 8, 2024 — CHELMSFORD, MASS. — ZOLL^®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received FDA clearance and CE mark* for a significant upgrade to the versatility of the Thermogard™ Temperature Management System.

Zoll Products

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!